Advertisement

Health technology assessments on histology-independent cancer drugs

    • 6 Accesses

    This is a preview of subscription content, log in to check access.

    Access options

    Buy single article

    Instant unlimited access to the full article PDF.

    US$ 49.95

    Price includes VAT for USA

    Subscribe to journal

    Immediate online access to all issues from 2019. Subscription will auto renew annually.

    US$ 214

    This is the net price. Taxes to be calculated in checkout.

    Reference

    1. Cooper S, et al. How should we assess the clinical and cost effectiveness of histology independent cancer drugs? BMJ 2020: l6435, No. 368, 2 Jan 2020. Available from: URL: https://doi.org/10.1136/bmj.l6435

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Health technology assessments on histology-independent cancer drugs. PharmacoEcon Outcomes News 844, 1 (2020) doi:10.1007/s40274-020-6464-7

    Download citation